Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Lasala

Interventional Cardiology Saint Louis, MO Medical Doctor

NPI 1982648317 CMS profile 90082

1 Barnes Jewish Hospital Plz, Div Im Cardiology, Saint Louis, MO 63110

Open in the dashboard

General payments

$936,113

1,228 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$58,826 paid to institutions, not to them · program years 2019–2023

Through program year 2025, John Lasala of Saint Louis, MO is reported in the CMS Open Payments database as having received $936,113 across 1,228 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $58,826 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $123,079 165
2024 General $170,862 143
2023 General $92,931 129
2022 General $199,387 249
2021 General $98,075 140
2020 General $86,531 148
2019 General $165,248 254

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Lasala
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to John Lasala were reported at $123,079. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year John Lasala Interventional Cardiology median Middle half National median
2019 $165,248 $1,097 $329–$3,048 $163
2020 $86,531 $473 $161–$1,480 $114
2021 $98,075 $677 $233–$1,827 $132
2022 $199,387 $978 $333–$2,724 $149
2023 $92,931 $1,136 $382–$2,986 $160
2024 $170,862 $1,181 $395–$3,326 $164
2025 $123,079 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Shockwave Medical, Inc $219,398 179 payments
  2. Abbott Laboratories $187,860 298 payments
  3. Boston Scientific Corporation $174,390 240 payments
  4. W. L. Gore & Associates, Inc. $135,154 104 payments
  5. Abiomed $97,155 156 payments
  6. Edwards Lifesciences Corporation $31,276 42 payments
  7. Chiesi USA, Inc. $23,921 31 payments
  8. Cordis US Corp. $17,790 26 payments
  9. Biotronik Inc. $13,973 50 payments
  10. AstraZeneca Pharmaceuticals LP $11,978 12 payments
  11. Other $23,219 90 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $325,113 123 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $183,063 60 payments
  3. Compensation for serving as faculty or as a speaker for a medical education program $165,020 42 payments
  4. Honoraria $118,541 39 payments
  5. Travel and Lodging $96,994 300 payments
  6. Food and Beverage $42,967 660 payments
  7. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $4,400 3 payments
  8. Education $16 1 payment
Products named General payments · program years 2019–2025
  1. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Lithoplasty $160,988 124 payments
  2. Impella $96,430 134 payments
  3. GORE CARDIOFORM Septal Occluder $83,982 45 payments
  4. AMPLATZER Occluders Cardiac Arrhythmias and Heart Failure $71,111 44 payments
  5. GORE CARDIOFORM ASD Occluder $45,887 21 payments
  6. CARDIOFORM Septal Occluder $42,926 38 payments
  7. AMPLATZER Occluders Structural Heart $32,939 33 payments
  8. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Cardiology $31,000 28 payments
  9. General - Vascular Access $29,707 22 payments
  10. Vascular Lithotripsy $27,381 25 payments
  11. Other $283,811 670 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$71,481

Medicare's payments for the services billed

Medicare patients

117

Average age 72

Services billed

331

46 women, 71 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 61%
Diabetes 53%
Arthritis 51%
Chronic kidney disease 50%
Atrial fibrillation 40%
COPD 37%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1,228 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record